Certain Prostate Cancer Patients May Benefit From Higher Radiation Doses in Fewer Sessions, Study Shows

Certain Prostate Cancer Patients May Benefit From Higher Radiation Doses in Fewer Sessions, Study Shows
Stereotactic body radiation therapy (SBRT) — a kind of radiation therapy that delivers high doses of radiation over a shorter treatment course — is as safe and effective as the traditional external beam radiation therapy (EBRT) for patients with low- and intermediate-risk prostate cancer, according to a long-term study. The study, "Long-Term Outcomes of Stereotactic Body Radiation Therapy for Low and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Consortium Study," was presented at the American Society for Radiation Oncology (ASTRO) 2018 Annual Meeting, held recently in San Antonio. Radiation therapy is a good alternative for patients with early-stage prostate cancer that has not migrated to other organs or adjacent tissues. However, the standard treatment course takes up to nine weeks with five treatments every week. SBRT offers a significantly shorter treatment course, with fewer radiotherapy sessions, by increasing the radiation dosage and focusing on th
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *